Do Patients With ACL Tears Demonstrate Weakness of the Soleus Muscle?
ACL
Do Patients With Anterior Cruciate Ligament (ACL) Tears Demonstrate Weakness of the Soleus Muscle?
1 other identifier
observational
55
1 country
1
Brief Summary
The goal of this prospective, cross-sectional study is to test the strength of the soleus muscle in participants who have a ACL tear confirmed by MRI. Previous studies have shown that the soleus muscle, which one of the muscles situated in the calf, decreases mechanical loading on the ACL. Therefore, we aim to test soleus muscle strength using a seated plantar flexor test. The main questions we aim to answer are:
- Do patients with ACL tears demonstrate inter-limb soleus strength asymmetry (\>10%)
- Do patients with ACL tears have soleus muscle weakness compared with uninjured (normative) participants?
- Do changes in soleus strength values correlate with patient reported outcomes and stability, as measured by the IKDC questionnaire? To achieve this the VALD force frame will be used as the testing device for plantar flexor strength testing. This device records the force generated by the movement. This will be repeated three times on each leg as part of the testing procedure. Furthermore, as part of the testing procedure participants will be required to fill out an IKDC form to assess their knee stability. Interrater reliability of the force frame will be investigated. Further data from participants without ACL tears will be used to compare results. Thus allowing us to see if people with ACL tears have a weakness in the soleus muscle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 17, 2024
CompletedFirst Submitted
Initial submission to the registry
January 23, 2024
CompletedFirst Posted
Study publicly available on registry
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
May 6, 2026
April 1, 2026
4 years
January 23, 2024
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Force generated
The primary outcome will be to measure the force generated by the soleus muscle in both limbs. This data will be normalised to their body weight to compare.
30 minutes
Secondary Outcomes (1)
IKDC score
5 minutes
Study Arms (2)
MRI-confirmed ACL tear group
This group will have had a complete ACL tear confirmed by MRI scan
Normative group
This group will provide normative data for the study. They will have no previous history of significant knee injury and no current symptomatic lower limb injuries.
Eligibility Criteria
A convenience sample of MRI-confirmed ACL injured patients, who are undergoing non-operative rehabilitation, will be recruited from Liverpool University Hospitals NHS Trust.. To account for potential bilateral weakness in muscle strength, normative values from a control group of healthy participants will be included. Healthy volunteers will be recruited from NHS staff at Liverpool University Hospitals NHS Foundation Trust. Volunteers will be approached directly via departmental email and face to face conversation or accepted via word of mouth. The international knee documentation committee (IKDC) questionnaire will be completed by the patient, to determine subjective knee stability.
You may qualify if:
- ACL tear participants:
- MRI-confirmed ACL tear.
- Participant is willing and able to give informed consent in writing for participation in the study.
- Male or Female, aged 18 years to 55 years of age.
You may not qualify if:
- Normative values from healthy individuals:
- No current or previous history of significant lower limb injury, or a history of previous minor injury that is symptomatic at the time of recruitment.
- No previous lower limb surgery.
- No course of medication, whether prescribed or over the counter, other than vitamins and mineral supplements or, for females, oral contraceptives.
- History of chronic musculoskeletal disease or disorder in either leg that may put the participants at risk because of participation in the study including non-united fractures, epilepsy, cardiac insufficiency, severe peripheral vascular disease, aneurysms, anticoagulant therapy, recent (\<3 months) radiotherapy or chemotherapy, long term steroid use (\>3 months), pregnancy, neurological disorders (e.g., Parkinson's disease), skin conditions at point of force testing, severe osteoporosis, malignancy, rheumatoid arthritis.
- Conditions or symptoms that may influence the result of the study, or the participant's ability to participate in the study including pain, limited range of motion, knee effusion, or anaemia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aintree Hospital, Liverpool University Hospitals NHS Foundation Trust
Liverpool, L9 7AL, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rachel Oldershaw
University of Liverpool
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 23, 2024
First Posted
February 1, 2024
Study Start
January 17, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
May 6, 2026
Record last verified: 2026-04